Showing 1041-1050 of 9426 results for "".
Learn More About REVIAN® Red Hair Growth System
https://practicaldermatology.com/topics/hair-nails/learn-more-about-revian-red-hair-growth-system/19750/Discover a new option for hair loss patients! REVIAN Red is a patented dual-band LED wireless cap for at-home use ten minutes daily. Click Here to Become a REVIAN Red Professional. REVIAN Red is indicated to treat androgenetic alopecia and to promote hair growth in males who have Norwood-Hamilton clInvestigating Hidradenitis Suppurativa: A Multifactorial Disease
https://practicaldermatology.com/programs/dermconsult/investigating-hidradenitis-suppurativa-a-multifactorial-disease/15261/How can we match our HS patients with the right therapy? Tune into this episode.Poster Pearl: Itch Control Matters Most to Patients with Moderate-to-Severe Atopic Dermatitis
https://practicaldermatology.com/programs/dermconsult/poster-pearl-itch-control-matters-most-to-patients-with-moderate-to-severe-atopic-dermatitis/15594/Dive into the findings from a poster featured at the 2023 Fall Clinical Dermatology conference.Beyond the Surface: The Impact of Psoriasis on Cardiovascular Health
https://practicaldermatology.com/programs/dermconsult/beyond-the-surface-the-impact-of-psoriasis-on-cardiovascular-health/24377/Here’s what dermatologists can do to prevent cardiovascular disease in patients with psoriasis.DermWireTV: Allē Launches; Arazlo Cleared; BTL Files Suit
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-alle-launches-arazlo-cleared-btl-files-suit/19714/More than 10 Years and 6 million members later, the Brilliant Distinctions program is being relaunched with a new name and a new app: Allē. Arazlo Lotion 0.045%, the first lotion formulation of tazarotene, is now FDA approved for the topical treatment of acne vulgaris in patients nine years of age aDermwireTV — Bayer Buys Merck’s OTC Lines, Allergan Rejects Valeant Bid
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-bayer-buys-merck-rsquo-s-otc-lines-allergan-rejects-valeant-bid/19134/Bayer Purchases Merck's OTC Products and Allergan Rebuffs Valeant. This week DermWireTV explores Bayer's growth in the OTC space, including sunscreens, and reports new data on skin cancer mortality. Also in this edition: Neal Bhatia, MD reviews the Noah Worcester Society Annual Meeting.DermwireTV — Revance’s Neurotoxin Promising, Celebs Fight Melanoma with L’Oreal
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-revance-rsquo-s-neurotoxin-promising-celebs-fight-melanoma-with-l-rsquo-oreal/19138/In this weeks DermwireTV, patient safety is explored, L'Oreal supports melanoma research and Revance reports positive data for novel neurotoxin.Coming Soon: New Biopsy Codes
https://practicaldermatology.com/topics/general-topics/coming-soon-new-biopsy-codes/20411/Is your practice prepared for changes to the CPT codes?Physician Spotlight: Shawn Kwatra, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-shawn-kwatra-md/23997/Physician Spotlight: Lesley Clark-Loeser, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-lesley-clark-loeser-md/23980/